<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01692873</url>
  </required_header>
  <id_info>
    <org_study_id>PACAomics / IPC 2011-004</org_study_id>
    <nct_id>NCT01692873</nct_id>
  </id_info>
  <brief_title>Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors</brief_title>
  <acronym>PACAomics</acronym>
  <official_title>Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Paoli-Calmettes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Paoli-Calmettes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreatic cancer is among the most serious human neoplasia and the most difficult to treat.

      Most patients present at diagnosis a non resectable, locally advanced or metastatic disease,
      with a median survival of 12 month.

      The aim of this study is the identification of diagnosis biomarkers, predictive of the
      therapeutic response.

      This project investigate the use of molecular analyses applied to pancreatic tumor cells
      collected by microbiopsy under ultrasound-endoscopy, and blood cells.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarkers</measure>
    <time_frame>within twenty four hours</time_frame>
    <description>Genomics, transcriptomics and proteomics analyses to determine presence or absence of biomarkers</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histology</measure>
    <time_frame>within twenty four hours</time_frame>
    <description>To determine the histologic characteristics of the pancreatic tumor</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pancreatic Tumor</condition>
  <arm_group>
    <arm_group_label>suspected pancreatic tumor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Realization of pancreatic tumor biopsy and blood samples</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>suspected pancreatic tumor</intervention_name>
    <description>Realization of pancreatic surgery to obtain tumor biopsy and blood samples to realize biomarkers analyses.</description>
    <arm_group_label>suspected pancreatic tumor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspicion of pancreatic adenocarcinoma

          -  Patient &gt; 18 years old

          -  Social Security affiliation

          -  Signed informed consent

        Exclusion Criteria:

          -  Patient in emergency situation

          -  Major person being the object of a legal protective measure or unable to express its
             consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marine GILABERT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Paoli-Calmettes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique GENRE, MD</last_name>
    <phone>33 (0)4 91 22 37 78</phone>
    <email>bec@ipc.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Agn√®s BOYER CHAMMARD, MD</last_name>
    <phone>33 (0)4 91 22 37 78</phone>
    <email>bec@ipc.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Marine GILABERT, MD</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.institutpaolicalmettes.fr/</url>
    <description>official web site of the sponsor</description>
  </link>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2012</study_first_submitted>
  <study_first_submitted_qc>September 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 25, 2012</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pancreatic tumor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

